Skip to Main Content

Why the Janssen/Johnson & Johnson Pause Should Make You Feel Safer


Thomas G. McGinn, MD, MPH System Executive Vice President, CommonSpirit Health

On Tuesday, April 13, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) jointly announced a recommendation to pause administration of the Janssen/Johnson & Johnson (J&J) vaccine as it undergoes further investigation for rare blood clotting events.

Publish date: 

Tuesday, May 25, 2021

News

Statement: IT Security Issue

OCT 05, 2022

CommonSpirit Health has identified an IT security issue that is impacting some of our facilities.

Read More Additional information about Statement: IT Security Issue

CommonSpirit Health Announces FY2022 Year End Results

SEP 23, 2022

CommonSpirit Health has released financial results for its 2022 fiscal year, which ended June 30.

Read More Additional information about CommonSpirit Health Announces FY2022 Year End Results